Trial intelligence / Profile preview

Metformin Effect on IGF in Metastatic Breast Cancer

NCT05840068Phase 4Completed

Sponsor
Beni Suef University
Start
Jun 2020
Primary completion
Jul 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of liquid metformin (Aspargo Labs) in breast cancer, sponsored by Beni Suef University. Started Jun 2020; status: completed.

02

Drugs

liquid metformin (Aspargo Labs)
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT05840068.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05840068.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call